The Cooper Companies, Inc. (NYSE:COO) on 6 march announced financial results for the fiscal first quarter ended January 31, 2014. The Cooper Companies, Inc. (NYSE:COO) stock opened at $136.65 in last session, and closed at $136.48, while the day range of The Cooper Companies, Inc. (NYSE:COO) stock is $133.00 – $145.34. The stock showed a positive weekly performance of 6.45%.
Ohr Pharmaceutical (NASDAQ:OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, and leading global cancer research center Cold Spring Harbor Laboratory (CSHL) announced the establishment of DepYmed Inc., a new joint venture to develop trodusquemine and related analogs. OHR Pharmaceutical Inc. (NASDAQ:OHRP) stock opened at $14.73 in last session, and closed at $17.73 by gaining 22.02%. The 52 week range of $4.11 – $17.85. Company’s market capitalization is $352.35 million.
Rockville-based Emergent BioSolutions Inc., (NYSE:EBS) which has been expanding its bio-defense business through acquisitions, reports an 11 percent increase in full-year revenue and reaffirms its 2014 forecast. Emergent Biosolutions Inc. (NYSE:EBS) stock increased 8.60% and finished the last session at $27.77. The EPS of the stock remained 0.87. Company’s market capitalization is $1.01 billion.
Corcept Therapeutics (NASDAQ:CORT) posted its quarterly earnings results on Wednesday. The company reported ($0.11) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.10) by $0.01, Analyst Ratings Network.com reports. The company had revenue of $4.10 million for the quarter, compared to the consensus estimate of $4.01 million. Corcept Therapeutics’ revenue was up 197.1% compared to the same quarter last year. Corcept Therapeutics Incorporated (NASDAQ:CORT) stock opened the session at $4.00, and closed the session at $4.08. The 52 week range of the Corcept Therapeutics Incorporated (NASDAQ:CORT) stock remained $1.47 – $4.19 and the day range was $3.92 – $4.19.